Serum matrix metalloproteinase-9 as a potential biomarker for obstructive sleep apnea severity
Sleep and Breathing · 2025-05 · 29 (2)
DOI: 10.1007/s11325-025-03287-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep and Breathing, online erschienen am 21.03.2025. Verfasst von So Yeon Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seou…. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Matrix Metalloproteinase 9. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul National University.
Abstract (Originalsprache)
Purpose
We aimed to investigate the associations between serum matrix metalloproteinase (MMP)-2 and MMP-9 levels and obstructive sleep apnea (OSA) severity with a focus on nocturnal hypoxemia.
Methods
The OSA patients ( n = 105) were recruited from a prospective sleep apnea cohort after polysomnography, with 27 healthy volunteers as the controls. OSA severity was assessed via the apnea–hypopnea index (AHI) and percent night time with SpO 2 < 90% (T90).
Results
The serum MMP-9 levels were significantly higher in the OSA patients (AHI ≥ 5/h, 68.8 ± 44.9 ng/mL) than the controls (49.0 ± 18.6 ng/mL, p < 0.001). The MMP-2 levels showed no significant differences. When grouped into T90 quartiles, the MMP-9 levels were higher in the OSA patients in the highest quartile compared to those in the lowest quartile or the controls (90.6 ± 56.3 ng/mL vs. 56.9 ± 31.9 ng/mL, p = 0.022; 90.6 ± 56.3 ng/mL vs. 49.0 ± 18.6 ng/mL, p = 0.002, respectively). The MMP-9 levels correlated with T90 and the AHI ( r = 0.36, p < 0.001; r = 0.35, p < 0.001, respectively). Multiple linear regression confirmed a significant association between MMP-9 and T90 after adjusting for body mass index, smoking status, and comorbidities (β = 0.53, p = 0.013). A similar association was observed for the AHI (β = 0.48, p = 0.019).
Conclusion
We concluded that serum MMP-9 levels are independently associated with OSA severity, particularly with T90 and the AHI, which suggests that MMP-9 could be a biomarker for OSA severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
- Protein Immunology Core Facility, Seoul National University Hospital Biomedical Research Institute Center for Medical Innovation, Seoul, Republic of Korea.
- Department of Internal Medicine, Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. apricot6@snu.ac.kr.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. apricot6@snu.ac.kr.
ORCID-Profile: Jaeyoung Cho
Förderung
- Seoul National University
Zitieren
APA
Kim, S. Y., Yoon, H., Choi, S. H., & Cho, J. (2025). Serum matrix metalloproteinase-9 as a potential biomarker for obstructive sleep apnea severity. Sleep and Breathing, 29(2). https://doi.org/10.1007/s11325-025-03287-2
Vancouver
Kim SY, Yoon H, Choi SH, Cho J. Serum matrix metalloproteinase-9 as a potential biomarker for obstructive sleep apnea severity. Sleep and Breathing. 2025;29(2). doi:10.1007/s11325-025-03287-2
BibTeX
@article{Kim2025,
author = {Kim, So Yeon and Yoon, Hyunyee and Choi, Seung Ho and Cho, Jaeyoung},
title = {Serum matrix metalloproteinase-9 as a potential biomarker for obstructive sleep apnea severity},
journal = {Sleep and Breathing},
year = {2025},
volume = {29},
number = {2},
doi = {10.1007/s11325-025-03287-2}
}
EUVIMED